GVK BIO Signs Definitive Agreement to Acquire Vanta Bioscience
- The acquisition enables GVK BIO to offer GLP toxicology services for Pharmaceuticals, Agrochemicals, Nutraceuticals, and Cosmetics
Complying with OECD GLP, ISO, USFDA GLP (21 CFR Part 58 rev. 2009) regulatory guidelines, the company offers toxicology evaluation services for the pharmaceutical, biotech, food supplements and feed additives industries. Vanta Bioscience also offers toxicology services using alternative methods for the Cosmetics industry.
The state-of-the-art facility is GLP and AAALAC accredited, is armed with high-end equipment, and has infrastructure like ‘Individually ventilated Cages’ and ‘Intelligent Building Management’ systems. The facility houses GLP trained scientific personnel with experience and expertise in study design and execution of regulatory directed studies leading to IND filings.
Speaking on the occasion, Manni Kantipudi, CEO, GVK BIO, said: “The acquisition is in line with our business strategy of being an integrated drug discovery services provider for our customers. We are constantly investing in upgrading our capabilities to provide world-class R&D services. Vanta Bioscience further advances our position as we expand our service offering in GLP toxicology.”
Gerard Schwickerath, Vice President and General Manager, Vanta Bioscience, said: “Vanta Bioscience team is pleased that the world-class research GLP and AAALAC accredited organization will continue under the direction of GVK BIO. We are delighted to transition into an organization that can expand our offerings and provide further opportunities to our clients and staff.”
About GVK BIO
GVK Biosciences (GVK BIO) is Asia’s leading Discovery Research and Development organization. GVK BIO provides a broad spectrum of integrated services across the R&D and manufacturing value chain with a focus on speed and quality. GVK BIO capabilities include Discovery Services, Contract Manufacturing, Formulations, Informatics and Clinical Development. www.gvkbio.com
About Vanta Bioscience
Vanta Bioscience offers safety and efficacy assessment services for clients in the pharmaceutical, biotech, medical device, cosmetics, agriculture, food supplements, feed additives and chemical industries, complying with OECD GLP, ISO, USFDA GLP (21 CFR Part 58 rev. 2009) regulatory guidelines. www.vantabio.com
Website: https://www.gvkbio.com/
Contact
GVK Biosciences
Dorothy Paul
(91) 40 6692 9904 (D)
dorothy.paul@gvkbio.com
Vanta Bioscience
Gerard Schwickerath
(1) 515-822-1875
Gerard.Schwickerath@vantabio.com
This news is a press release provided by GVK Biosciences. Korea Newswire follows these editorial guidelines.
-
2020년 3월 4일 13:28
-
2020년 3월 4일 13:19